Spineway S.A (ALSPW) | Financial Analysis & Statements
Spineway S.A. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
30.2M
Total Liabilities
6.3M
Shareholders Equity
23.9M
Debt to Equity
0.27
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Spineway S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 12.0M | 10.5M | 7.4M | 4.3M | 3.4M |
| Cost of Goods Sold | 3.5M | 2.6M | 1.4M | 826.0K | 412.1K |
| Gross Profit | 8.5M | 7.9M | 6.0M | 3.5M | 3.0M |
| Gross Margin % | 70.7% | 74.9% | 80.5% | 80.7% | 87.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 1.8M | 2.1M |
| Other Operating Expenses | 2.3M | 4.6M | 3.4M | 1.5M | 1.4M |
| Total Operating Expenses | 2.3M | 4.6M | 3.4M | 3.3M | 3.5M |
| Operating Income | -885.0K | -4.3M | -3.2M | -1.4M | -1.8M |
| Operating Margin % | -7.4% | -40.6% | -42.9% | -32.9% | -51.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | 329.7K | 52.5K |
| Interest Expense | 93.0K | 66.0K | 38.0K | 49.0K | 12.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -3.9M | -6.5M | -3.1M | -1.6M | -14.0M |
| Income Tax | - | - | 0 | 0 | -231.6K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -3.9M | -6.5M | -3.1M | -1.6M | -13.6M |
| Net Margin % | -32.3% | -61.9% | -42.2% | -36.9% | -402.1% |
| Key Metrics | |||||
| EBITDA | -1.1M | -3.4M | -2.0M | -252.0K | -918.1K |
| EPS (Basic) | €0.00 | €-0.82 | €0.00 | €-0.20 | €-48,193.74 |
| EPS (Diluted) | €0.00 | €-0.82 | €0.00 | €-0.20 | €-48,193.74 |
| Basic Shares Outstanding | 145792276 | 7972 | 11451540 | 196 | 282 |
| Diluted Shares Outstanding | 145792276 | 7972 | 11451540 | 196 | 282 |
Income Statement Trend
Spineway S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.5M | 1.8M | 5.5M | 13.9M | 4.8M |
| Short-term Investments | - | - | - | 5.0M | - |
| Accounts Receivable | 3.2M | 2.7M | 2.0M | 1.7M | 1.1M |
| Inventory | 4.7M | 4.4M | 3.9M | 2.4M | 1.9M |
| Other Current Assets | 1.0K | - | 1.0K | - | - |
| Total Current Assets | 13.9M | 10.2M | 12.1M | 18.6M | 8.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 5.9M | 5.5M | 4.7M | 6.1M | 0 |
| Goodwill | 9.5M | 14.7M | 14.7M | 2.6M | 1.3M |
| Intangible Assets | - | 3.9M | 3.9M | 1.5M | 1.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.0K | 1.0K | 1.0K | 24.8K | 297.4K |
| Total Non-Current Assets | 16.5M | 16.2M | 15.6M | 6.9M | 6.6M |
| Total Assets | 30.4M | 26.3M | 27.7M | 25.6M | 14.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 984.0K | 1.6M | 1.6M | 1.2M | 823.5K |
| Short-term Debt | 153.0K | 484.0K | 772.0K | 1.1M | 359.4K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 655.0K | 97.0K | 1.5M | 863.0K | -90 |
| Total Current Liabilities | 4.2M | 4.9M | 2.5M | 2.1M | 1.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.7M | 2.1M | 2.9M | 2.4M | 2.7M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | 1.0K | -1.0K | 1.0K | 1.0K |
| Total Non-Current Liabilities | 1.9M | 2.4M | 3.2M | 2.6M | 3.0M |
| Total Liabilities | 6.2M | 7.3M | 5.7M | 4.7M | 4.7M |
| Equity | |||||
| Common Stock | 58.0K | 286.0K | 182.0K | 1.6M | 463.3K |
| Retained Earnings | -3.9M | -6.5M | -3.1M | -1.6M | -13.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 24.2M | 19.1M | 22.0M | 20.9M | 10.2M |
| Key Metrics | |||||
| Total Debt | 1.8M | 2.6M | 3.7M | 3.5M | 3.1M |
| Working Capital | 9.7M | 5.3M | 9.6M | 16.5M | 6.6M |
Balance Sheet Composition
Spineway S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -3.9M | -6.5M | -3.1M | -1.6M | -685.0K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | -1.3M | 140.0K | -668.0K | 0 |
| Operating Cash Flow | -3.9M | -6.9M | -3.1M | -2.5M | -685.0K |
| Investing Activities | |||||
| Capital Expenditures | - | -794.0K | - | - | 0 |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | -582.0K | -50.0K |
| Investment Sales | - | - | - | 0 | 2.0K |
| Investing Cash Flow | - | -724.0K | -10.2M | -1.2M | -48.0K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 1.5M | 288.0K | 24.8M | 12.6M |
| Debt Repayment | - | -808.0K | -5.1M | -298.0K | -13.5M |
| Financing Cash Flow | - | 3.5M | 3.6M | 10.7M | 872.0K |
| Free Cash Flow | -3.3M | -7.3M | -1.6M | -1.8M | -1.3M |
| Net Change in Cash | -3.9M | -4.1M | -9.7M | 7.0M | 139.0K |
Cash Flow Trend
Spineway S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.20
Forward P/E
-2.31
Price to Book
0.25
Price to Sales
0.45
PEG Ratio
-2.31
Profitability Ratios
Profit Margin
-17.47%
Operating Margin
-13.23%
Return on Equity
-9.46%
Return on Assets
-4.45%
Financial Health
Current Ratio
2.16
Debt to Equity
6.63
Beta
0.19
Per Share Data
EPS (TTM)
€0.01
Book Value per Share
€0.65
Revenue per Share
€0.37
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALSPW | 5.8M | 16.20 | 0.25 | -9.46% | -17.47% | 6.63 |
| Sartorius Stedim | 15.8B | 59.45 | 3.86 | 6.59% | 8.98% | 63.11 |
| Crossject S.A | 105.6M | - | - | 212.74% | 0.00% | -4.61 |
| Visiomed Group SA | 52.8M | 59.67 | - | 3.64% | 45.95% | 0.32 |
| Bonyf N.V | 2.5M | - | 5.72 | -32.61% | 8.02% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.